Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

Clinical trial NCT03367741 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03367741
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Endometrial Carcinoma Metastatic Endometrial Carcinoma Recurrent Endometrial Carcinoma Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Start date: 2018-04-16
Primary completion: 2025-05-09
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.